Home/Investors/Claris Ventures

Claris Ventures

Biotech Investor · 2 portfolio companies

Portfolio

2

Combined Value

$98K

Focus Areas

4

Top Stage

Pre-clinical

Investment Focus

Antibody Discovery Cell & Gene Therapy Vaccine Development Oncology

Portfolio Companies

Company	Stage	Valuation	Focus
Telesis Bio	—	$98K	Antibody Discovery, Cell & Gene Therapy
NeoPhore	Pre-clinical	—	Oncology

Frequent Co-Investors

Northpond Ventures1 shared Bristol Myers Squibb1 shared 3B Future Health Fund1 shared Innovate UK1 shared 2Invest1 shared Sixth Element Capital LLP1 shared Astellas Venture Management1 shared NEVA SGR1 shared